ADC Therapeutics SA (ADCT)

ADC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	231.01	261.34	250.87	278.6	326.44	466.54
Cash & Short-Term Investments	231.01	261.34	250.87	278.6	326.44	466.54
Cash Growth	18.65%	4.17%	-9.95%	-14.66%	-30.03%	6.23%
Accounts Receivable	31.05	29.12	20.32	25.18	72.97	30.22
Inventory	4.78	4.18	2.25	16.18	18.56	11.12
Other Current Assets	9.94	11.7	17.82	16.33	28.04	17.3
Total Current Assets	276.77	306.34	291.25	336.29	446.02	525.18
Net Property, Plant & Equipment	1.2	1.3	13.43	16.13	9.98	11.23
Other Intangible Assets	-	-	-	-	14.36	13.58
Long-Term Investments	-	-	-	1.65	31.15	41.24
Other Long-Term Assets	13.53	15.52	17.3	0.71	27.66	26.74
Total Assets	291.5	323.15	321.98	354.78	529.17	617.97

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.3	9.18	18.03	15.57	12.35	12.08
Accrued Expenses	57.7	57.99	62.44	52.1	-	3.75
Short-Term Debt	-	-	-	-	-	6.58
Current Portion of Long-Term Debt	4.64	3	-	-	12.47	-
Current Portion of Leases	-	-	-	-	1.1	1.03
Other Current Liabilities	-	-	-	-	73.04	50.5
Total Current Liabilities	67.63	70.16	80.47	67.67	98.96	73.94
Long-Term Debt	111.04	112.45	113.63	112.73	97.24	-
Long-Term Leases	0.99	1.03	8	10.18	6.56	6.99
Other Long-Term Liabilities	328.21	325.34	322.53	312.45	212.35	218.66
Total Long-Term Liabilities	440.25	438.82	444.15	435.36	316.16	225.66
Total Liabilities	507.87	508.98	524.62	503.03	440.44	451.88

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	11.23	11.08	8.43	7.31	7.31	6.45
Treasury Stock	-0.21	-0.21	-0.22	-0.54	-0.68	-0.13
Additional Paid-in Capital	1,442	1,440	1,284	1,181	1,163	1,084
Accumulated Other Comprehensive Income	-0.8	-0.52	-1.42	-0.09	-0.36	0.18
Retained Earnings	-1,669	-1,636	-1,493	-1,335	-1,081	-924.89
Shareholders' Equity	-216.38	-185.83	-202.64	-148.25	88.73	166.09
Total Liabilities & Equity	291.5	323.15	321.98	354.78	529.17	617.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	116.67	116.49	121.63	122.91	117.38	14.6
Net Cash (Debt)	114.34	144.85	129.24	155.69	209.07	451.95
Net Cash Growth	56.69%	12.08%	-16.99%	-25.53%	-53.74%	4.59%
Net Cash Per Share	0.82	1.14	1.33	1.91	2.59	5.88
Book Value	-216.38	-185.83	-202.64	-148.25	88.73	166.09
Book Value Per Share	-1.56	-1.46	-2.09	-1.81	1.10	2.16
Tangible Book Value	-216.38	-185.83	-202.64	-148.25	74.37	152.51
Tangible Book Value Per Share	-1.56	-1.46	-2.09	-1.81	0.92	1.99

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error